TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases-Reference-Cited by-同舟云学术

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

Published:2014-07-08 Issue:3 Volume:146 Page:557-566
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Anders Carey,Deal Allison M.,Abramson Vandana,Liu Minetta C.,Storniolo Anna M.,Carpenter John T.,Puhalla Shannon,Nanda Rita,Melhem-Bertrandt Amal,Lin Nancy U.,Kelly Marcom P.,Van Poznak Catherine,Stearns Vered,Melisko Michelle,Smith J. Keith,Karginova Olga,Parker Joel,Berg Jonathan,Winer Eric P.,Peterman Amy,Prat Aleix,Perou Charles M.,Wolff Antonio C.,Carey Lisa A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-3039-y.pdf

Reference34 articles.

1. Lin NU et al (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer. Cancer 113(10):2638–2645

2. Niwińska A, Murawska M, Pogoda K (2010) Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol 21(5):942–948

3. Niwińska A, Murawska M, Pogoda K (2010) Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases. Cancer 116(18):4238–4247

4. Licht S, et al. (2011) Mechanism of action of iniparib: stimulation of reactive oxygen species (ROS) production in an iniparib-sensitive breast cancer cell line. Mol Cancer Ther 10(11 Suppl: Abstract A226)

5. Castro M, Li L, Stallings T (2010) Pharmacokinetics of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in cerebrospinal fluid (CSF) of a patient with breast cancer with carcinomatous meningitis. J Clin Oncol (Meet Abstr) 28:e13559

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC);Journal of Oncology Pharmacy Practice;2023-08-09

2. An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer;Medicine;2023-07-28

3. TME-targeted approaches of brain metastases and its clinical therapeutic evidence;Frontiers in Immunology;2023-05-09

4. Systemic treatments for breast cancer brain metastasis;Frontiers in Oncology;2023-01-06

5. Update on the Management of Brain Metastasis;Neurotherapeutics;2022-10